Furoslim®

Furoslim™ African Mango Seed Extract

Irvingia gabonensis Seed Extract | 8% Albumin Standardised Extract

A standardised African mango seed extract characterised by its 8% albumin content and studied in relation to body weight, waist circumference and metabolic health markers.

8% Albumin African Mango Seed Weight Management Context Metabolic Health Markers
Furoslim African mango seed extract capsules with powder

Introduction

Furoslim™ is a branded extract derived from the seeds of Irvingia gabonensis, a West African plant commonly referred to as African mango or bush mango.

The seeds have a long history of traditional dietary use in West Africa, where they are valued for their thickening properties and satiating effect when consumed as part of meals.

In modern research, Irvingia gabonensis seed extracts have been investigated in relation to body weight management and metabolic health markers in overweight individuals. Human clinical studies have explored changes in body weight, waist circumference, lipid markers and glucose-related parameters.

Technical Specification

Specification Detail
Ingredient Name Furoslim™ African Mango Seed Extract
Botanical Source Irvingia gabonensis
Common Names African Mango, Bush Mango
Plant Part Used Seed kernel
Extract Type Standardised African mango seed extract
Standardisation 8% Albumin
Typical Serving 250mg daily
Typical Use Weight management and metabolic health focused formulations

Botanical Identity & Standardisation

The seed kernels of Irvingia gabonensis contain a combination of soluble fibre, protein fractions and other bioactive constituents.

Furoslim™ is standardised to 8% albumin, a seed protein fraction discussed in the literature in relation to satiety signalling and metabolic regulation.

Standardisation supports a consistent composition across batches and finished formulations.

Key Extract Features

  • Derived from Irvingia gabonensis seed kernels
  • Standardised to 8% albumin
  • Contains seed protein fractions and soluble fibre
  • Studied in overweight adult populations
  • Positioned for weight and metabolic health applications

Albumin Standardisation

Albumin is a seed protein fraction used to characterise Furoslim™. Standardisation to 8% albumin supports a more consistent ingredient profile.

Why Standardisation Matters

Botanical seed extracts can vary depending on raw material composition and processing. Standardisation supports a more consistent and transparent approach to formulation.

  • Defined albumin content
  • Consistent seed extract composition
  • Improved formulation transparency
  • Reproducibility across batches

Composition & Analytical Characterisation

Furoslim™ is a concentrated seed extract designed for use in food supplement formulations. While the exact phytochemical profile of Irvingia gabonensis seeds is complex, analytical characterisation typically focuses on the ingredient’s key compositional features.

  • Protein fractions, including albumin
  • Soluble fibre content, contributing to viscosity and satiety context
  • Low inherent sugar and fat content relative to whole seeds

This compositional profile underpins the ingredient’s positioning in weight and metabolic health applications.

Evidence Context & Proposed Pathways

Research into Irvingia gabonensis seed extracts has explored several physiological pathways relevant to metabolic health.

Research Pathways

  • Satiety and appetite regulation, potentially influenced by soluble fibre and protein fractions
  • Adipose tissue signalling, including hormones such as leptin and adiponectin
  • Lipid and glucose metabolism, examined through changes in blood markers

These pathways are discussed in scientific literature as part of broader investigations into dietary fibres and seed-derived bioactives.

They provide a contextual framework for interpreting human study outcomes but should be viewed as part of a developing evidence base.

Human Clinical Research

Body Weight & Waist Circumference

Randomised, double-blind, placebo-controlled trials conducted in overweight adult populations have reported reductions in body weight and waist circumference following supplementation with Irvingia gabonensis seed extract over intervention periods of approximately 8–12 weeks.

These changes were observed alongside dietary guidance and are consistent with the ingredient’s proposed role in supporting weight-management strategies.

Metabolic & Lipid Marker Context

  • Total cholesterol and triglyceride markers
  • Fasting glucose-related parameters
  • Adipose-related hormones such as leptin and adiponectin
  • Broader metabolic health research context

Evidence Quality Considerations

Systematic reviews of randomised controlled trials have concluded that, while individual studies report positive outcomes, the overall evidence base for Irvingia gabonensis remains limited by the number of trials and variability in study design and reporting quality.

As such, findings should be interpreted within the context of a developing evidence base.

Safety & Tolerability

Across published human studies and reviews, Irvingia gabonensis seed extract has generally been described as well tolerated when consumed by healthy adults over short- to medium-term study periods.

  • Reported adverse effects were typically mild and transient
  • Gastrointestinal discomfort or headache were reported in a small number of participants
  • No serious safety concerns identified in the available clinical literature

Evidence-Led Use Context

Based on its composition and published human research, Furoslim™ is commonly discussed in relation to weight management, waist circumference, metabolic markers and satiety research.

Weight Management
Waist Circumference
Metabolic Markers
Satiety Context
Lifestyle Support

These potential benefits reflect trends observed in controlled human studies and are influenced by overall dietary and lifestyle context.

Typical Intake

Furoslim™ is commonly formulated at a 250mg daily serving in food supplement products.

Formulation Context

Furoslim™ is suitable for formulations focused on African mango seed extract, albumin standardisation and weight-management related applications.

Summary

Furoslim™ is a standardised Irvingia gabonensis seed extract characterised by its 8% albumin content and investigated in human clinical research focused on weight and metabolic health markers.

Controlled trials have reported changes in body weight and waist circumference alongside selected metabolic parameters, while systematic reviews highlight the need for further high-quality research.

When used as part of a balanced diet and healthy lifestyle, Furoslim™ represents a botanically derived ingredient positioned for weight and metabolic health support with an emerging, but still developing, evidence base.

Furoslim™ African Mango Seed Extract Capsules

A single-ingredient formulation using Furoslim™ African mango seed extract, standardised to 8% albumin.

View Product

References

  1. Ngondi J.L. et al. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids in Health and Disease, 2005.
  2. Ngondi J.L. et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, reduces body weight and improves metabolic parameters in overweight subjects in a randomized double-blind placebo-controlled investigation. Lipids in Health and Disease, 2009.
  3. Onakpoya I. et al. The use of Irvingia gabonensis in the management of overweight and obesity: a systematic review of randomized clinical trials. Journal of Dietary Supplements, 2013.
  4. Nonsa-ard R. et al. Effects of Irvingia gabonensis seed extract on metabolic and inflammatory markers in overweight adults: a 12-week randomized study. Nutrients, 2022.
× Expanded product document image